### 11185 Federal Register / Vol. 75, No. 46 / Wednesday, March 10, 2010 / Notices

E STIMATED 

### A NNUALIZED 

### B URDEN 

### H OURS

Type of respondents Number of respondents Number of responses per

respondent Average burden per response (in hours)

Demonstrators .................................................................................................................. ........... 30 1 15/60 Demonstrators .................................................................................................................. ........... 30 1 15/60 Demonstrators .................................................................................................................. ........... 30 1 15/60 Demonstrators .................................................................................................................. ........... 30 1 3 Observers ...................................................................................................................... .............. 170 1 15/60 Observers ...................................................................................................................... .............. 170 1 15/60 Observers ...................................................................................................................... .............. 170 1 15/60 Observers ...................................................................................................................... .............. 170 1 3

Dated: March 4, 2010. Maryam Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010–5156 Filed 3–9–10; 8:45 am]

**BILLING CODE 4163–18–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**National Institutes of Health**

**Submission for OMB Review; Comment Request; Reinstatement of**  **OMB No. 0925–0601/exp. 02/28/2010, Request for Human Embryonic Stem**  **Cell Line To Be Approved for Use in NIH Funded Research** 

**ACTION :**  Correction notice.

On March 2, 2010 the National Institutes of Health published a notice in the Federal Register (75 FR 9418) with a 30-day comment period seeking public comment for an information collection entitled ‘‘Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research ’’

.

In the second paragraph of the notice entitled, ‘‘Proposed Collection, ’’ the annual reporting burden reflected in the notice is corrected to read: ‘‘Estimated Number of Respondents: 100; Estimated Number of Responses per Respondent: 1; Average Burden Hours Per Response: 3; and Estimated Total Annual Burden Hours Requested: 300. The estimated annualized cost to respondents is $10,500. ’’

All other information in the notice is correct and remains unchanged.

Dated: March 2, 2010. Mikia Currie, Office of Policy for Extramural Research Administration, OD, National Institutes of Health.
[FR Doc. 2010–5020 Filed 3–9–10; 8:45 am]

**BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND**  **HUMAN SERVICES**
**Office of the Secretary**

**Centers for Medicare & Medicaid Services; Delegation of Authority** 

Notice is hereby given that I have delegated to the Administrator, Centers for Medicare & Medicaid Services (CMS), or his or her successor, the authorities currently vested in the Secretary under section 1135 [42 U.S.C. 1320b–5] of Title XI of the Social Security Act, and as may hereafter be amended, to temporarily waive or modify requirements during certain emergencies or disasters that are related to Medicare, Medicaid, and the Children’s Health Insurance Programs as they pertain to the mission of CMS.

The authorities under section 1135 [42 U.S.C. 1320b–5] of the Social Security Act, and as may hereafter be amended, may be re-delegated.

Limitations

1. The authority to make the initial decision to invoke the waiver authorities under section 1135 [42 U.S.C. 1320b–5] upon the occurrence of the two conditions precedent specified in section 1135(g) [42 U.S.C. 1320b– 5(g)] is excluded from this delegation and is reserved by me.

2. The following authorities under section 1135 [42 U.S.C. 1320b–5] of the Social Security Act, and as may hereafter be amended, are excluded from this delegation of authority:

— Section 1135(b)(7) pertaining to sanctions and penalties that arise from noncompliance with certain requirements of regulations promulgated under section 264(c) of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) [42 U.S.C. 1320d–2 note]. The authority to waive the HIPAA regulations at 45 of the Code of Federal Regulations, Part 164 will continue to be held by me.

— Section 1135(d) to provide a certification and advance written notice to Congress at least two days before exercising the authority with respect to an emergency area is reserved by me.

— Section 1135(f) to report to Congress regarding the approaches used to accomplish the purposes described in section 1135(a) [42 U.S.C. 1320b–5] of the Social Security Act, including an evaluation of such approaches and recommendations for improved approaches should the need for such emergency authority arise in the future is reserved by me.

3. The authorities under section 1135 [42 U.S.C. 1320b–5] shall be exercised under the Department’s policy on regulations and the existing delegation of authority to approve and issue regulations.

I hereby affirm and ratify any actions taken by the Administrator, CMS, or his or her subordinates, which involved the exercise of the authorities under section 1135 [42 U.S.C. 1320b–5] delegated herein prior to the effective date of this delegation of authority.

This delegation of authority is effective immediately.

Authority: 44 U.S.C. 3101.
Kathleen Sebelius, Secretary.
[FR Doc. 2010–4992 Filed 3–9–10; 8:45 am]

**BILLING CODE 4120–01–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Substance Abuse and Mental Health Services Administration** 

**Center for Substance Abuse Prevention; Notice of Cancellation of**  **Meeting**

Pursuant to Public Law 92–462, notice is hereby given of a cancellation of the March 8, 2010 meeting of the Substance Abuse and Mental Health Services Administration (SAMHSA) Drug Testing Advisory Board (DTAB).

Public notice was given in the Federal Register on February 19, 2010 (Volume